A medical AI startup in Omaha, Neb., has received the FDA’s blessing to market software for diagnosing prostate cancer on MRI scans.
A medical AI startup in Omaha, Neb., has received the FDA’s blessing to market software for diagnosing prostate cancer on MRI scans.